Table 1.
The distribution of histologic subtypes in PLB.
| Histologic type (ICD-O-3) | Number | Percentage |
|---|---|---|
| Diffuse large B-cell lymphoma, NOS (9680) | 1703 | 66.58% |
| Non-Hodgkin lymphoma, NOS (9591) | 314 | 12.28% |
| Follicular lymphoma (9698) | 166 | 6.49% |
| Lymphoid neoplasm, NOS (9590) | 111 | 4.34% |
| Chronic/small lymphocytic, NOS (9670) | 49 | 1.92% |
| Anaplastic large cell lymphoma, T-cell and null cell type (9714) | 44 | 1.72% |
| Burkitt lymphoma, NOS (9687) | 34 | 1.33% |
| Marginal zone B-cell lymphoma, NOS (9699) | 30 | 1.17% |
| Precursor NHL, NOS (9727) | 29 | 1.14% |
| Lymphoplasmacytic lymphoma (9671) | 24 | 0.94% |
| Classical Hodgkin lymphoma, NOS (9650) | 17 | 0.66% |
| Peripheral T-cell lymphoma, NOS (9702) | 12 | 0.47% |
| Mantle-cell lymphoma (9673) | 9 | 0.35% |
| Nodular sclerosis classical Hodgkin lymphoma (9663) | 7 | 0.27% |
| NHL, NOS, T-cell (9684) | 5 | 0.20% |
| NK/T-cell lymphoma, nasal and nasal-type (9719) | 2 | 0.08% |
| Primary effusion lymphoma (9678) | 1 | 0.04% |
| Composite Hodgkin lymphoma and NHL (9596) | 1 | 0.04% |
| Total patients with PLB | 2558 | 100.00% |
ICD, International Classification of Diseases; NHL, non-Hodgkin lymphoma; NK, natural killer (cell); NOS, not otherwise specified; PLB, primary lymphoma of bone.